Severe Acute Motor Axonal Neuropathy Associated with Influenza-A (H1N1) Infection and Prolonged Respiratory Failure - A Case Report

1Willison H, Jacobs B, Doorn P. Guillain-Barré syndrome. Lancet. 2016;388:717-727. Willison H Jacobs B Doorn P Guillain-Barré syndrome Lancet 2016388717–72710.1016/S0140-6736(16)00339-1Search in Google Scholar

2McGrogan A, Madle G, Seaman H, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32:150-163. McGrogan A G Madle H Seaman Vries CS de The epidemiology of Guillain-Barré syndrome worldwide A systematic literature review. Neuroepidemiology 200932150–16310.1159/000184748Search in Google Scholar

3Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469-482. den Berg B Van C Walgaard J Drenthen C Fokke BC Jacobs Doorn PA van Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis Nat Rev Neurol 201410469–48210.1038/nrneurol.2014.121Search in Google Scholar

4Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294-2304. Yuki N Hartung HP Guillain-Barré syndrome N Engl J Med 20123662294–230410.1056/NEJMra1114525Search in Google Scholar

5Cortese A, Baldanti F, Tavazzi E, et al. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature. J Neurol Sci. 2012;312:173-176. Cortese A Baldanti F Tavazzi E et al Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature J Neurol Sci 2012312173–17610.1016/j.jns.2011.08.047Search in Google Scholar

6Hahn A F. Guillain-Barre syndrome. Lancet. 1998;352:635641. Hahn A F Guillain-Barre syndrome Lancet 199835263564110.1016/S0140-6736(97)12308-XSearch in Google Scholar

7Muhammad W, Qaseem A, Amray A. Post Vaccination Guillain Barre Syndrome: A Case Report. Cureus. 2018;10: e2511. Muhammad W Qaseem A Amray A Post Vaccination Guillain Barre Syndrome: A Case Report Cureus 201810 e2511Search in Google Scholar

8Salmon D, Proschan M, Forshee R, et al. Association between Guillain-Barré syndrome and influenza A (H1N1)2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381:1461-1468. Salmon D Proschan M Forshee R et al Association between Guillain-Barré syndrome and influenza A (H1N1)2009 monovalent inactivated vaccines in the USA: a meta-analysis Lancet 20133811461–146810.1016/S0140-6736(12)62189-8Search in Google Scholar

9Sejvar J, Baughman A, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123-133. Sejvar J Baughman A Wise M Morgan OW Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis Neuroepidemiology 201136123–13310.1159/000324710570304621422765Search in Google Scholar

10Hafer-Macko C, Hsieh ST, Ho WT, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996;40:635-644. Hafer-Macko C Hsieh ST Ho WT et al Acute motor axonal neuropathy: an antibody-mediated attack on axolemma Ann Neurol 199640635–64410.1002/ana.4104004148871584Search in Google Scholar

11Khatib H, Naous A, Ghanem S, Dbaibo G, Rajab M. Case report: Guillain-Barre syndrome with pneumococcus - A new association in pediatrics. IDCases. 2017;11:36-38. Khatib H Naous A Ghanem S Dbaibo G Rajab M Case report: Guillain-Barre syndrome with pneumococcus - A new association in pediatrics IDCases 20171136–3810.1016/j.idcr.2017.11.009577346929387550Search in Google Scholar

12Li-Syue L, Chung C, Wu Y, et al. Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country. J Neurol Sci. 2016;369:159-164. Li-Syue L Chung C Wu Y et al Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country J Neurol Sci 2016369159–16410.1016/j.jns.2016.08.01427653883Search in Google Scholar

13Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608-1613. Alshekhlee A Hussain Z Sultan B Katirji B Guillain-Barré syndrome: incidence and mortality rates in US hospitals Neurology 2008701608–161310.1212/01.wnl.0000310983.38724.d418443311Search in Google Scholar

14Ruiz E, Ramalle-Gomara E, Quinones C, Martínez-Ochoa E. Trends in Guillain-Barré syndrome mortality in Spain from 1999 to 2013. Int J Neurosci. 2016;126:985-988. Ruiz E Ramalle-Gomara E Quinones C Martínez-Ochoa E Trends in Guillain-Barré syndrome mortality in Spain from 1999 to 2013 Int J Neurosci 2016126985–98810.3109/00207454.2015.109043726335975Search in Google Scholar

15Stoian A, Motataianu A, Bajko Z, Balasa A. Guillain–Barré and Acute Transverse Myelitis Overlap Syndrome Following Obstetric Surgery. JCCM. 2020;6:74-79. Stoian A Motataianu A Bajko Z Balasa A Guillain–Barré and Acute Transverse Myelitis Overlap Syndrome Following Obstetric Surgery JCCM 2020674–7910.2478/jccm-2020-0008702940132104735Search in Google Scholar

16Van der Berg B, Bunschoten C, A van Doorn P, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80:1650-1654. der Berg B Van C Bunschoten van Doorn P A BC Jacobs Mortality in Guillain-Barre syndrome Neurology 2013801650–165410.1212/WNL.0b013e3182904fcc23576619Search in Google Scholar

17Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Guillain-Barré syndrome and related diseases after influenza virus infection. Neurol Neuroimmunol Neuroinflamm. 2019;6:e575. Yamana M Kuwahara M Fukumoto Y Yoshikawa K Takada K Kusunoki S Guillain-Barré syndrome and related diseases after influenza virus infection Neurol Neuroimmunol Neuroinflamm 20196e57510.1212/NXI.0000000000000575662408831355311Search in Google Scholar

18Tripp A. Acute transverse myelitis and Guillain-Barre overlap syndrome following influenza infection. CNS Spectr. 2008;13(9):744-746. Tripp A Acute transverse myelitis and Guillain-Barre overlap syndrome following influenza infection CNS Spectr 200813 9 744–74610.1017/S109285290001384518849892Search in Google Scholar

19Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015;86:1186-1195. Uncini A Kuwabara S Nodopathies of the peripheral nerve: an emerging concept J Neurol Neurosurg Psychiatry 2015861186–119510.1136/jnnp-2014-31009725699569Search in Google Scholar

20Zhang Li C, Po Lai Ho, Kintner D, Sun D, Chiu SY. Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves. J Neurosci. 2010;30:3555-3566. Li C Zhang Lai Ho Po D Kintner D Sun SY Chiu Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves J Neurosci 2010303555–356610.1523/JNEUROSCI.4551-09.2010354843220219989Search in Google Scholar

21Simpson B, Rajabally Y. Sensori‐motor Guillain‐Barré syndrome with anti‐GD1b antibodies following influenza A infection. Eur J Neurol. 2009;16:e81. Simpson B Rajabally Y Sensori‐motor Guillain‐Barré syndrome with anti‐GD1b antibodies following influenza A infection Eur J Neurol 200916e8110.1111/j.1468-1331.2009.02569.x19222546Search in Google Scholar

22Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123:1487-1495. Uncini A Kuwabara S Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update Clin Neurophysiol 20121231487–149510.1016/j.clinph.2012.01.025Search in Google Scholar

23Kaida K. Guillain-Barre syndrome. Adv Exp Med Biol. 2019;1190:323-331. Kaida K Guillain-Barre syndrome Adv Exp Med Biol 20191190323–33110.1007/978-981-32-9636-7_20Search in Google Scholar

24Park S, Pai K, Kim J, Shin JII. The role of interleukin 6 in the pathogenesis of hyponatremia associated with Guillain-Barré syndrome. Nefrologia. 2012;32:114. Park S Pai K Kim J Shin JII The role of interleukin 6 in the pathogenesis of hyponatremia associated with Guillain-Barré syndrome Nefrologia 201232114Search in Google Scholar

25Press R, Ozenci V, Kouwenhoven M, Link H. Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome. Neurology. 2002;58:476-478. Press R Ozenci V Kouwenhoven M Link H Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome Neurology 200258476–47810.1212/WNL.58.3.476Search in Google Scholar

26Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao GS, Rao S. Complications in mechanically ventilated patients of Guillain–Barre syndrome and their prognostic value. J Neurosci Rural Pract. 2017;8:68–73. Netto AB Taly AB Kulkarni GB Maheshwara Rao GS Uma S Rao Complications in mechanically ventilated patients of Guillain–Barre syndrome and their prognostic value J Neurosci Rural Pract 2017868 7310.4103/0976-3147.193542Search in Google Scholar

27Kutlesa M, Santini M, Krajinovic V, Raffanelli D, Barsić B. Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocrit Care. 2010;13:98-100. Kutlesa M Santini M Krajinovic V Raffanelli D B Barsić Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection Neurocrit Care 20101398–10010.1007/s12028-010-9365-ySearch in Google Scholar

28Tam C, O’Brien S, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One. 2007;2:e344. Tam C S O’Brien Petersen I Islam A Hayward A Rodrigues LC Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database PLoS One 20072e34410.1371/journal.pone.0000344Search in Google Scholar

29Winer JB. Guillain-Barré syndrome: clinical variants and their pathogenesis. J Neuroimmunol. 2011;231:70-72. Winer JB Guillain-Barré syndrome: clinical variants and their pathogenesis J Neuroimmunol 201123170–7210.1016/j.jneuroim.2010.09.017Search in Google Scholar

30Verity C, Stellitano L, Winstone A, Andrews N, Stowe J, Miller E. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children. Lancet. 2011;378:1545-1546. Verity C Stellitano L Winstone A Andrews N Stowe J Miller E Guillain-Barré syndrome and H1N1 influenza vaccine in UK children Lancet 20113781545–154610.1016/S0140-6736(11)61665-6Search in Google Scholar

31Liu S, Dong C, Ubogu E. Immunotherapy of Guillain-Barré syndrome. Hum Vaccin Immunother. 2018;14:2568-2579. Liu S Dong C Ubogu E Immunotherapy of Guillain-Barré syndrome Hum Vaccin Immunother 2018142568–257910.1080/21645515.2018.1493415631440129953326Search in Google Scholar

32Stoian A, Motataianu A, Barcutean L, et al. Understanding the mechanism of action of intravenous immunoglobulins: a ten years’ experience in treating Guillain Barré syndrome. Farmacia. 2020;68:3. Stoian A Motataianu A Barcutean L et al Understanding the mechanism of action of intravenous immunoglobulins: a ten years’ experience in treating Guillain Barré syndrome Farmacia 202068310.31925/farmacia.2020.3.7Search in Google Scholar

33Hughes R, Swan A, Raphaël JC, Annane D, van Konigsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130:2245-2257. Hughes R Swan A Raphaël JC Annane D Konigsveld R van Doorn PA van Immunotherapy for Guillain-Barré syndrome: a systematic review Brain 20071302245–225710.1093/brain/awm00417337484Search in Google Scholar